PureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting ...

Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel ther ...

RAHWAY, N.J., December 09, 2024--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the Phase 3 KEYLYNK-001 trial evaluating KEYTRUDA ...

Based on the significant unmet medical need in the treatment of GAD along with the initial clinical data from the Phase 2b ...

The strength of girl cadets in the NCC has risen to 40 per cent and a phase-wise expansion has been planned for the Corps in the next few years, senior officials said on Friday.      At a press ...

It was found that glepaglutide, a long-acting GLP-2 analogue, when given twice weekly as subcutaneous delivery via auto-injector in SBS patients met the primary endpoint in the EASE 1 phase 3 trial.

A roundup of predictions, opinions from writers at USA TODAY’s Ducks Wire ahead of the Oregon Ducks Rose Bowl game vs. Ohio ...

initiative from 1 January 2025. Abhay Karandikar, secretary, Department of Science and Technology (DST), said Tuesday at a press conference that the ONOS initiative will be implemented in three phases ...

The New Year's Day event, which killed one and injured seven, garnered reactions online ridiculing CEO Elon Musk and ...

Rep. Jasmine Crockett talks with Ali Velshi about the Republican chaos threatening to entangle House Speaker Mike Johnson in ...

The NCC's female cadet strength has reached 40%, and the organization plans to expand gradually. The Republic Day camp ...

NEW YORK, January 02, 2025 -- ( BUSINESS WIRE )-- One Equity Partners ("OEP"), a middle market private equity firm, today announced that it has completed an investment in EthosEnergy, a global ...